These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N. Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500 [Abstract] [Full Text] [Related]
3. Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women with vulvovaginal candidiasis. Ray D, Goswami R, Dadhwal V, Goswami D, Banerjee U, Kochupillai N. J Infect; 2007 Oct; 55(4):374-7. PubMed ID: 17692922 [Abstract] [Full Text] [Related]
5. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society. Mendling W, Brasch J, German Society for Gynecology and Obstetrics, Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, German Society of Dermatology, the Board of German Dermatologists, German Speaking Mycological Society. Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657 [Abstract] [Full Text] [Related]
6. Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis. Sood G, Nyirjesy P, Weitz MV, Chatwani A. Infect Dis Obstet Gynecol; 2000 Jul; 8(5-6):240-3. PubMed ID: 11220485 [Abstract] [Full Text] [Related]
7. Vulvovaginal candidiasis in a Flemish patient population. De Vos MM, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T, Nailis H, Dhont MA, Rodriguez-Tudela JL, Nelis HJ. Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555 [Abstract] [Full Text] [Related]
8. Candida lusitaniae as an unusual cause of recurrent vaginitis and its successful treatment with intravaginal boric acid. Silverman NS, Morgan M, Nichols WS. Infect Dis Obstet Gynecol; 2001 Dec; 9(4):245-7. PubMed ID: 11916183 [Abstract] [Full Text] [Related]
9. FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE. Khameneie KM, Arianpour N, Roozegar R, Aklamli M, Amiri MM. East Afr Med J; 2013 Apr; 90(4):117-23. PubMed ID: 26866095 [Abstract] [Full Text] [Related]
10. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Guaschino S, De Seta F, Sartore A, Ricci G, De Santo D, Piccoli M, Alberico S. Am J Obstet Gynecol; 2001 Mar; 184(4):598-602. PubMed ID: 11262459 [Abstract] [Full Text] [Related]
11. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L. Rev Argent Microbiol; 2001 Mar; 33(4):217-22. PubMed ID: 11833253 [Abstract] [Full Text] [Related]
13. Prevalence and management of non-albicans vaginal candidiasis. Hettiarachchi N, Ashbee HR, Wilson JD. Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368 [Abstract] [Full Text] [Related]
14. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials. Pitsouni E, Iavazzo C, Falagas ME. Am J Obstet Gynecol; 2008 Feb; 198(2):153-60. PubMed ID: 18068146 [Abstract] [Full Text] [Related]